ResearcherOsaka Ohtani UniversityNo recent work listed

Keita Yamada

ORCID-verified (high confidence)As of 9 November 2026

Matched on ORCID iD 0000-0002-5266-0698; OpenAlex author ID A5102951396.

Their work

Papers: 2 (first author 1, last author 0)
Trials: 0
Grants: 0
Collaborators: 3

Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: 1 paper

Papers 2

Circulating natural antibodies against 3'-sialyllactose complement the diagnostic performance of CA19-9 for the early detection of pancreatic ductal adenocarci… First author DOI 10.3233/cbm-190158 ↗
Generation of Rat Monoclonal Antibodies Against Human Pancreatic Ductal Adenocarcinoma Cells. Co-author DOI 10.1089/mab.2016.0012 ↗

Closest collaborators

The 3 strongest of 3 ranked by shared papers, trials and grants, with recent and small-team work weighing most.

Kiyoshi Higashi · 2 shared papers, 2016–2020
- Paper Circulating natural antibodies against 3'-sialyllactose complement the diagnostic performance of CA19-9 for the early d… DOI 10.3233/cbm-190158 ↗
- Paper Generation of Rat Monoclonal Antibodies Against Human Pancreatic Ductal Adenocarcinoma Cells. DOI 10.1089/mab.2016.0012 ↗
Koichi Saito · 2 shared papers, 2016–2020
- Paper Circulating natural antibodies against 3'-sialyllactose complement the diagnostic performance of CA19-9 for the early d… DOI 10.3233/cbm-190158 ↗
- Paper Generation of Rat Monoclonal Antibodies Against Human Pancreatic Ductal Adenocarcinoma Cells. DOI 10.1089/mab.2016.0012 ↗
Taro Tachibana · 1 shared paper, 2016
- Paper Generation of Rat Monoclonal Antibodies Against Human Pancreatic Ductal Adenocarcinoma Cells. DOI 10.1089/mab.2016.0012 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.